5th Gene Therapy Analytical Development Europe Summit returns to Boston!
R&D
As the approvals for gene therapy in Europe are expected to increase rapidly in the coming year, it is crucial to have robust analytics to support the transition from research and development (R&D) to commercial validation.
The 5th Gene Therapy Analytical Development Europe Summit is returning to London in May 2024, bringing together experts in analytical development specialising in bioassays, molecular biology, and physicochemical property characterisation.
VIEW THE FULL EVENT GUIDE HERE
Join your peers in 2024 to:
- DISCOVER ways leading companies are employing novel analytical tools to overcome regulatory hurdles and accelerate approval
- BUILD lasting connections and initiate collaboration on analytical challenges
- GAIN expert insights in various vector modalities across different stages of the drug development pipeline
- SUPERCHARGE your potency assay development by addressing the end-end analytical challenges associated with potency testing
Secure your place here or get in touch with the team – info@hansonwade.com
